MetaCap

Who Owns Kymera Therapeutics Stock?

NASDAQ: KYMRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

115.31-4.08 (-3.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
116.67%
Institutional holders
427
  • Institutions 96.8%
  • Insiders 3.2%
  • Public and other 0.0%

Who owns Kymera Therapeutics stock?

Institutional investors own about 116.7% of Kymera Therapeutics's shares, spread across 427 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.22% of KYMR.

The largest institutional holders are FMR, LLC (14.72%), Baker Bros. Advisors, LP (10.14%) and Avoro Capital Advisors LLC (8.76%). Together, the top 10 institutions control 72.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their KYMR positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of KYMR

Kymera Therapeutics top institutional holders
InstitutionShares% HeldChange
FMR, LLC12.57M14.72%+1.8%
Baker Bros. Advisors, LP8.66M10.14%0.0%
Avoro Capital Advisors LLC7.47M8.76%0.0%
Price (T.Rowe) Associates Inc7.11M8.33%+17.4%
T. Rowe Price Investment Management, Inc.6.26M7.33%+14.5%
Blackrock Inc.5.83M6.82%+5.2%
BVF Inc.3.87M4.54%-29.6%
Wellington Management Group, LLP3.68M4.30%-5.5%
Vanguard Capital Management LLC3.04M3.57%+3.8%
Vanguard Portfolio Management LLC2.98M3.49%-0.5%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of KYMR

Kymera Therapeutics top fund holders
FundShares% Held
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund2.28M2.67%
T. Rowe Price New Horizons Fund, Inc.2.26M2.64%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.09M2.45%
T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App2.05M2.40%
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund1.80M2.10%
iShares Trust-iShares Russell 2000 ETF1.62M1.90%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.51M1.77%
SmallCap World Fund Inc1.32M1.54%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.07M1.25%
TR PRICE-Price (T.Rowe) New Horizons Trust1.02M1.19%

Frequently asked questions

Who is the largest shareholder of Kymera Therapeutics?

FMR, LLC is the largest institutional shareholder of KYMR, owning 14.72% of shares outstanding (12.57M shares) as of its latest 13F filing.

What percentage of Kymera Therapeutics is owned by institutions?

Institutions own about 116.7% of KYMR shares and 120.6% of the public float.

How much of Kymera Therapeutics do insiders own?

Insiders, such as officers and directors, own about 3.22% of KYMR shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related